Zubin Punthakee1, Pilar Paniagua Iglesias2, Pablo Alonso-Coello3, Ignasi Gich4, Inmaculada India5, Germán Malaga6, Ruben Diaz Jover5, Hertzel C Gerstein7, P J Devereaux7. 1. McMaster University and Population Health Research Institute, Hamilton, ON, Canada. Electronic address: zubin.punthakee@mcmaster.ca. 2. Servicio de Anestesiología y Reanimación, Instituto de Investigación Biomédica (IIB Sant Pau), Barcelona, Spain. Electronic address: ppaniagua@santpau.cat. 3. Centro Cochrane Iberoamericano, Instituto de Investigación Biomédica (IIB Sant Pau-CIBERESP), Barcelona, Spain. 4. Department of Clinical Epidemiology and Public Health, HSCSP CIBER de Salud Mental (CIBERSAM), Barcelona, Spain. 5. Servicio de Anestesiología y Reanimación, Instituto de Investigación Biomédica (IIB Sant Pau), Barcelona, Spain. 6. Universidad Peruana Cayetano Heredia, Lima, Peru. 7. McMaster University and Population Health Research Institute, Hamilton, ON, Canada.
Abstract
BACKGROUND: Myocardial injury after non-cardiac surgery (MINS) is the most common perioperative cardiovascular complication and is independently associated with 30-day mortality. We aimed to assess the association between preoperative glucose concentration and postoperative MINS and mortality. METHODS: The VISION study is a prospective cohort study done at 12 centres in eight countries. Patients aged 45 years or older who required at least one overnight hospital admission for non-cardiac surgery were enrolled from Aug 6, 2007, to Jan 11, 2011. In the GlucoVISION analysis, we assessed the relations between preoperative casual or fasting glucose concentration and MINS within 3 days after surgery using logistic regression, and 30-day mortality using Cox proportional regression, in people with and without diabetes. FINDINGS: 11 954 patients were included in this analysis, of whom 2809 (23%) had diabetes. Within the first three postoperative days, MINS occurred in 813 (7%) patients. 249 (2%) patients died by day 30. More patients with diabetes had MINS (odds ratio [OR] 1·98 [95% CI 1·70-2·30]; p<0·0001), and died (OR 1·41 [1·08-1·86]; p=0·016) than did patients without diabetes. Casual glucose concentrations were associated with MINS in all patients (adjusted OR 1·06 [1·04-1·09] per 1 mmol/L increment in glucose; p=0·0003), and with death in patients without diabetes (adjusted hazard ratio [HR] 1·13 [95% CI 1·05-1·23] per mmol/L; p=0·002). We noted a progressive relation between unadjusted fasting glucose concentration and both MINS (OR 1·14 [1·08-1·20] per mmol/L; p<0·0001), driven by the effect in the subgroup without previous diabetes (pinteraction=0·025), and 30-day mortality (HR 1·10 [1·02-1·19] per mmol/L; p=0·013). For patients without diabetes, casual glucose of more than 6·86 mmol/L and fasting glucose of more than 6·41 mmol/L predicted MINS (OR 1·71 [1·36-2·15]; p<0·0001, and OR 2·71 [1·85-3·98]; p<0·0001, respectively). For patients with diabetes, only casual glucose concentration more than 7·92 mmol/L predicted MINS (OR 1·47 [1·10-1·96]; p=0·0096). INTERPRETATION: Preoperative glucose concentration, particularly casual glucose concentration, predicts risk for postoperative cardiovascular outcomes, especially in patients without diabetes. FUNDING: Full funding sources listed at the end of the paper (see Acknowledgments).
BACKGROUND:Myocardial injury after non-cardiac surgery (MINS) is the most common perioperative cardiovascular complication and is independently associated with 30-day mortality. We aimed to assess the association between preoperative glucose concentration and postoperative MINS and mortality. METHODS: The VISION study is a prospective cohort study done at 12 centres in eight countries. Patients aged 45 years or older who required at least one overnight hospital admission for non-cardiac surgery were enrolled from Aug 6, 2007, to Jan 11, 2011. In the GlucoVISION analysis, we assessed the relations between preoperative casual or fasting glucose concentration and MINS within 3 days after surgery using logistic regression, and 30-day mortality using Cox proportional regression, in people with and without diabetes. FINDINGS: 11 954 patients were included in this analysis, of whom 2809 (23%) had diabetes. Within the first three postoperative days, MINS occurred in 813 (7%) patients. 249 (2%) patients died by day 30. More patients with diabetes had MINS (odds ratio [OR] 1·98 [95% CI 1·70-2·30]; p<0·0001), and died (OR 1·41 [1·08-1·86]; p=0·016) than did patients without diabetes. Casual glucose concentrations were associated with MINS in all patients (adjusted OR 1·06 [1·04-1·09] per 1 mmol/L increment in glucose; p=0·0003), and with death in patients without diabetes (adjusted hazard ratio [HR] 1·13 [95% CI 1·05-1·23] per mmol/L; p=0·002). We noted a progressive relation between unadjusted fasting glucose concentration and both MINS (OR 1·14 [1·08-1·20] per mmol/L; p<0·0001), driven by the effect in the subgroup without previous diabetes (pinteraction=0·025), and 30-day mortality (HR 1·10 [1·02-1·19] per mmol/L; p=0·013). For patients without diabetes, casual glucose of more than 6·86 mmol/L and fasting glucose of more than 6·41 mmol/L predicted MINS (OR 1·71 [1·36-2·15]; p<0·0001, and OR 2·71 [1·85-3·98]; p<0·0001, respectively). For patients with diabetes, only casual glucose concentration more than 7·92 mmol/L predicted MINS (OR 1·47 [1·10-1·96]; p=0·0096). INTERPRETATION: Preoperative glucose concentration, particularly casual glucose concentration, predicts risk for postoperative cardiovascular outcomes, especially in patients without diabetes. FUNDING: Full funding sources listed at the end of the paper (see Acknowledgments).
Authors: Willem van den Boom; Rebecca A Schroeder; Michael W Manning; Tracy L Setji; Gic-Owens Fiestan; David B Dunson Journal: Diabetes Care Date: 2018-02-13 Impact factor: 19.112
Authors: Meera Kotagal; Rebecca G Symons; Irl B Hirsch; Guillermo E Umpierrez; E Patchen Dellinger; Ellen T Farrokhi; David R Flum Journal: Ann Surg Date: 2015-01 Impact factor: 12.969
Authors: H H H Feringa; R Vidakovic; S E Karagiannis; M Dunkelgrun; A Elhendy; E Boersma; M R H M van Sambeek; P G Noordzij; J J Bax; D Poldermans Journal: Diabet Med Date: 2008-01-14 Impact factor: 4.359
Authors: N Sarwar; P Gao; S R Kondapally Seshasai; R Gobin; S Kaptoge; E Di Angelantonio; E Ingelsson; D A Lawlor; E Selvin; M Stampfer; C D A Stehouwer; S Lewington; L Pennells; A Thompson; N Sattar; I R White; K K Ray; J Danesh Journal: Lancet Date: 2010-06-26 Impact factor: 202.731
Authors: Hertzel C Gerstein; Karl Swedberg; Jonas Carlsson; John J V McMurray; Eric L Michelson; Bertil Olofsson; Marc A Pfeffer; Salim Yusuf Journal: Arch Intern Med Date: 2008-08-11
Authors: P J Devereaux; David Bradley; Matthew T V Chan; Mike Walsh; Juan Carlos Villar; Carisi Anne Polanczyk; Beatriz Graeff S Seligman; Gordon H Guyatt; Pablo Alonso-Coello; Otavio Berwanger; Diane Heels-Ansdell; Nicole Simunovic; Holger Schünemann; Salim Yusuf Journal: Open Med Date: 2011-12-13
Authors: Ashham Mansur; Aron Frederik Popov; Ameen Abu Hanna; Ingo Bergmann; Ivo Florian Brandes; Tim Beissbarth; Martin Bauer; José Hinz Journal: Medicine (Baltimore) Date: 2015-11 Impact factor: 1.817
Authors: Maria Isabel Del Olmo-García; David Hervás Marín; Jana Caudet Esteban; Antonio Ballesteros Martin-Portugués; Alba Cerveró Rubio; Miguel Angel Arnau Vives; Ana Catalá Gregori; Maite Penalba Martínez; Juan Francisco Merino-Torres Journal: J Int Med Res Date: 2020-06 Impact factor: 1.671